Security key
61559X104
MoonLake Immunotherapeutics - COMMON STOCK (MLTX)
CUSIP: 61559X104
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 344,446
- Total 13F value
- $4,030,017
- Share change
- -56,826
- SEC-reported price per share
- $11.70
- Number of holders
- 10
- Value change
- -$688,151
- Number of buys
- 5
- Number of sells
- 6
- Shares outstanding
- 80,766,491
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
10
Top holders
10
MLTX full security history
Ownership snapshot
Full 13F holder table
MoonLake Immunotherapeutics SEC filings
MoonLake Immunotherapeutics company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61559X104
Recent filing periods:
Ownership snapshot
Top reported holders of MLTX - MoonLake Immunotherapeutics - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BIOTECHNOLOGY VALUE FUND L P
Disclosed value leader
BVF INC/IL
Comparable rows
8/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 20%
7 rows are not safely comparable across share classes.
13D/G row: BIOTECHNOLOGY VALUE FUND L P
Showing 1-6 of 15 holder rows.
Quick read
BIOTECHNOLOGY VALUE FUND L P leads the comparable SEC ownership view at 20%.
8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BIOTECHNOLOGY VALUE FUND L P's linked filing trail.
Comparable ownership
Top 5
BIOTECHNOLOGY VALUE FUND L P
20%
Deep Track Capital, LP
9.7%
T. Rowe Price Investment Manageme...
5.3%
PRICE T ROWE ASSOCIATES INC /MD/
4.7%
Cormorant Asset Management, LP
4.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
3/4/5
BVF PARTNERS L P/IL · Director, 10%+ Owner
|
20%
Reported 13D/G
· 25 Jun 2026
|
$298,903,985
16,001,284 shares
|
$0 | 25 Jun 2026 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
9.7%
Reported 13D/G
· 30 Jun 2026
|
$162,860,149
7,999,025 shares
|
+$68,999,103 | 30 Jun 2026 |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
Company
|
5.3%
Reported 13D/G
· 30 Jun 2026
|
$87,153,505
4,280,624 shares
|
$0 | 30 Jun 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
T. Rowe Price Associates, Inc. · Company
|
4.7%
Reported 13D/G
· 31 Mar 2025
|
$117,334,991
2,974,271 shares
|
-$14,571,725 | 31 Mar 2025 |
| Cormorant Asset Management, LP |
13D/G
13F
Company
|
4.4%
Reported 13D/G
· 30 Jun 2026
|
$65,262,616
3,205,433 shares
|
-$25,959,000 | 30 Jun 2026 |
| Avoro Capital Advisors LLC |
13D/G
|
3.2%
Reported 13D/G
· 30 Sep 2025
|
$14,340,000
2,000,000 shares
|
-$15,415,500 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
344,446
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
172
Q3 2026 holders
10
Holder diff
-162
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend